XML 24 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 17,676 $ 23,603 $ 49,107 $ 70,692
General and administrative 12,947 4,276 62,852 12,476
Total operating expenses 30,623 27,879 111,959 83,168
Operating loss (30,623) (27,879) (111,959) (83,168)
Interest income 2,618 2,005 6,710 6,254
Other income, net 62 223 321 616
gain from change in fair value of warrant liabilities, liability 0 0 108,183 0
Net income (loss) $ (27,943) $ (25,651) $ 3,255 $ (76,298)
Shares used in computing net income (loss) per share, basic (in shares) 47,976 42,002 45,734 41,845
Net income (loss) per share, basic (in dollars per share) $ (0.58) $ (0.61) $ 0.07 $ (1.82)
Net income (loss) $ (27,943) $ (25,651) $ 3,255 $ (76,298)
Adjustment for change in fair value of warrant liabilities 0 0 (43,793) 0
Adjusted numerator, diluted $ (27,943) $ (25,651) $ (40,538) $ (76,298)
Shares used in computing net income (loss) per share, diluted (in shares) 47,976 42,002 46,101 41,845
Net income (loss) per share, diluted (in dollars per share) $ (0.58) $ (0.61) $ (0.88) $ (1.82)